Wealthcare Advisory Partners LLC Alaunos Therapeutics, Inc. Transaction History

Wealthcare Advisory Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$2.26 - $3.27 $112,999 - $163,500	-50,000 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$3.02 - $4.94 $90,600 - $148,200	-30,000 Reduced 37.5%	50,000 $151,000
Q1 2018 May 15, 2018	BUY	$3.46 - $5.14 $276,800 - $411,200	80,000 New	80,000 $314,000
Q4 2017 Feb 14, 2018	SELL	$4.0 - $6.54 $4,000 - $6,540	-1,000 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$4.99 - $6.57 $4,990 - $6,570	1,000	1,000 $6,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $424M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.